HP
HBM Partners
HBM Partners is a Series B to Series C stage investment firm. It has made 10 investments. Their most common stage is series-c (64% of deals). Average disclosed round size is $69.7M (across 7 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
DD
Didier De Montmollin
Partner
FD
Francesco DAmico
Partner
PB
Priyanka Belawat
Partner
GM
Gavin MacGregor
Global Healthcare Investment Analyst
MJ
Michael Jasulavic
Healthcare Analyst
CP
Chandra P. Leo
Investment Professional
MF
Matthias Fehr
Head Private Equity / Investor for Growth Equity
RK
Romain Kooger
Investment Advisor
IS
Ivo Staijen
Portfolio management for healthcare/biotechnology companies
UG
Ulrich Geilinger
Head of Private Equity
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| NNumab Therapeutics | Series C | $55M | Jan 2025 |
 4TEEN4 Pharmaceuticals | Series C | — | Jan 2025 |
 Numab | Series C | — | May 2021 |
| IITEOS THERAPEUTICS | Series B | $125M | Apr 2020 |
| IITEOS THERAPEUTICS | Unknown | — | Jan 2020 |
 SphingoTec | Series C | — | Jan 2018 |
| NNabriva | Series B | $120M | Jan 2015 |
| SSyrrx | Series C | $18.5M | Oct 2000 |
| HHookipa Biotech | Series C | $59.6M | — |
| MMahzi | Unknown | $60M | — |
| OOphthotech | Series C | $50M | — |
Top Co-Investors
Boxer Capital3 shared
HBM Healthcare Investments3 shared
Forbion3 shared
Novo Capital3 shared
Wellington Management2 shared
Brandenburg Kapital2 shared
WuXi Healthcare Ventures2 shared
MPM Capital2 shared
Fund+2 shared
RA Capital Management2 shared
The Invus Group, LLC2 shared
BVF Partners L.P.2 shared
Cormorant Asset Management2 shared
Omega Funds1 shared
OrbiMed1 shared
Novartis Venture Fund1 shared
Vivo Capital1 shared
Think.Health1 shared
NRW.BANK1 shared
Last updated: 19 September 2026